Belvedere Trading’s TCR2 Therapeutics Inc. Common Stock TCRR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2023
Q1
Sell
-31,992
Closed -$32K 735
2022
Q4
$32K Buy
31,992
+15,676
+96% +$15.7K ﹤0.01% 230
2022
Q3
$26K Buy
+16,316
New +$26K ﹤0.01% 91
2022
Q2
Hold
0
387
2021
Q1
Hold
0
240
2020
Q4
Hold
0
134